Search the Newsreel

TradingKey

This article provides a detailed quarterly and annual balance sheet analysis for Integra Lifesciences Holdings Corp (IART) from FY2012Q1 to FY2026Q1, highlighting various asset, liability, and equity metrics. It allows users to evaluate the company's financial health, fundamentals, and key ratios. The report includes …

Integra Lifesciences Holdings Corp (IART) Cash Flow Statement

This article presents the quarterly and annual cash flow statements for Integra Lifesciences Holdings Corp (IART), allowing users to assess the company's financial health. It includes detailed breakdowns of operating, investing, and financing cash flows, along with frequently asked questions defining these terms and …

PT Sinar Mas Multiartha Tbk Class A Revenue Breakdown – IDX:SMMA

Integra LifeSciences Holdings Corporation Revenue Breakdown – NASDAQ:IART

Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History

This article provides a comprehensive overview of Integra LifeSciences Holdings Corporation (IART), including its current stock price, financial statistics, and company profile. It details the company's performance, product offerings in medical devices, and recent analyst ratings. The information aims to give investors a snapshot …

Integra Lifesciences Holdings Corp (IART) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Integra Lifesciences Holdings Corp (IART), noting its weak financial status but high operating efficiency. The company's financial score is 6.96, ranking 121 out of 200 in its industry. Integra Lifesciences recently reported a 2.42% year-over-year revenue increase …

Kaskela Law Firm Announces Investigation of Integra LifeSciences

Kaskela Law Firm has launched an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) following the filing of a securities fraud complaint. The complaint alleges that Integra made false and misleading statements regarding systemic cGMP violations and product quality issues from March 2019 to …

Integra Lifesciences Holdings Corp|Price:19.790|Chg%:+1.230

Integra Lifesciences Holdings Corp (IART) saw a price increase of 6.63% to $19.790, with its fundamentals noted as stable and growth potential high, despite technical indicators not fully supporting the current trend. The stock is currently trading sideways, suitable for range-bound swing trading, and …

How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story

Integra LifeSciences Holdings recently drew attention after a run of earnings beats and favorable analyst assessments coincided with preparations for its second-quarter 2026 results release and conference call, now in the past. The combination of a consistent pattern of topping earnings expectations and upward …

Integra LifeSciences to announce Q2 2026 results on July 29

Integra LifeSciences Holdings Corporation announced it will release its second-quarter 2026 financial results on July 29, 2026, before the market opens. Following the release, the management team will host a conference call at 8:30 a.m. ET to discuss the results and outlook, with a …

Integra LifeSciences to Release Results Before Market Open July 29

Integra LifeSciences (NASDAQ: IART) announced that it will release its second-quarter 2026 financial results on Wednesday, July 29, 2026, before the market opens. Management will host an earnings conference call at 8:30 a.m. ET, which will be accessible via live webcast and replay on …

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Integra LifeSciences Holdings Corporation will release its second quarter 2026 financial results on Wednesday, July 29, 2026, before the market opens. Following the release, the management team will host a conference call at 8:30 a.m. ET, with a live webcast available on the company's …

Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue?

Why Integra LifeSciences (IART) Stock Is Trading Up Today

The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call

Integra LifeSciences (IART) Stock Trades Down, Here Is Why

Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

PT Bank Multiarta Sentosa Tbk (MASB.JK) company profile and facts

PT Bank Multiarta Sentosa Tbk (MASB.JK) stock price, news, quote and history